IL-2 蛋白
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| IL-2 Protein (AA 21-153) (His tag) | 人 | HEK-293 Cells |
|
|
|
| IL-2 Protein (His tag) | 小鼠 | 大肠杆菌(E. Coli) |
|
|
|
| IL-2 Protein (AA 21-153) | 人 | 大肠杆菌(E. Coli) |
|
|
|
| IL-2 Protein (His tag) | 人 | 大肠杆菌(E. Coli) |
|
|
|
| IL-2 Protein (His tag) | Pig | 大肠杆菌(E. Coli) |
|
|
|
| IL-2 Protein (AA 21-155) (His tag) | 大鼠 | 大肠杆菌(E. Coli) |
|
|
|
| IL-2 Protein (AA 21-155) (His tag) | 大鼠 | 大肠杆菌(E. Coli) |
|
|
|
| IL-2 Protein (AA 21-155) (His tag) | 大鼠 | HEK-293 Cells |
|
|
|
| IL-2 Protein (AA 21-155, full length) (hFc Tag) | 大鼠 | Mammalian Cells |
|
|
|
| IL-2 Protein (AA 21-153) (His tag) | 人 | HEK-293 Cells |
|
|
|
| IL-2 Protein (AA 21-155) (SUMO Tag) | 大鼠 | 大肠杆菌(E. Coli) |
|
|
|
| IL-2 Protein (AA 21-169) (His tag) | 小鼠 | HEK-293 Cells |
|
|
|
| IL-2 Protein (AA 21-155) (hFc Tag) | 大鼠 | HEK-293 Cells |
|
|
|
| IL-2 Protein (AA 21-155) | 大鼠 | HEK-293 Cells |
|
|
|
| IL-2 蛋白 | 人 | HEK-293 Cells |
|
|
|
| IL-2 Protein (AA 21-169) (His tag) | 小鼠 | 大肠杆菌(E. Coli) |
|
|
|
| IL-2 Protein (AA 21-155) (GST tag) | 大鼠 | 大肠杆菌(E. Coli) |
|
|
|
| IL-2 Protein (AA 1-153) (His tag) | 人 | HEK-293 Cells |
|
|
|
| IL-2 Protein (AA 21-153) (His-Avi Tag,Biotin) | 人 | HEK-293 Cells |
|
|
|
| IL-2 Protein (AA 21-155) (His tag) | 大鼠 | 大肠杆菌(E. Coli) |
|
|
- 宿主
- 人
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- WB (Western Blotting: 所列应用)
- 宿主
- 小鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- >98 %
- 生物活性
- Active
- Func (Functional Studies: 所列应用)
- 宿主
- 人
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- 生物活性
- Active
- WB (Western Blotting: 所列应用)
- 宿主
- 人
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- >98 %
- 生物活性
- Active
- WB (Western Blotting: 所列应用)
- 宿主
- Pig
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- >98 %
- 生物活性
- Active
- Imm (Immunogen: 所列应用)
- 宿主
- 大鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- Imm (Immunogen: 所列应用)
- 宿主
- 大鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- Imm (Immunogen: 所列应用)
- 宿主
- 大鼠
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- 宿主
- 大鼠
- 宿主
- Mammalian Cells
- 蛋白类型
- Recombinant
- 纯度
- Greater than 95 % as determined by SDS-PAGE.
- CC (Cell Culture: 所列应用)
- 宿主
- 人
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- 生物活性
- Active
- Imm (Immunogen: 所列应用)
- 宿主
- 大鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- CC (Cell Culture: 所列应用)
- 宿主
- 小鼠
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- 生物活性
- Active
- Imm (Immunogen: 所列应用)
- 宿主
- 大鼠
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- Imm (Immunogen: 所列应用)
- 宿主
- 大鼠
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- Imm (Immunogen: 所列应用)
- 宿主
- 小鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 90 % as determined by reducing SDS-PAGE.
- Imm (Immunogen: 所列应用)
- 宿主
- 大鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 90 % as determined by reducing SDS-PAGE.
- Imm (Immunogen: 所列应用)
- 宿主
- 人
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- CC (Cell Culture: 所列应用)
- 宿主
- 人
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 90 % as determined by reducing SDS-PAGE.
- 生物活性
- Active
- Imm (Immunogen: 所列应用)
- 宿主
- 大鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
Latest Publications for our IL-2 蛋白
: "CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells." in: Cancer immunology research, Vol. 2, Issue 9, pp. 878-89, (2014) (PubMed).
: "CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis." in: Cancer immunology research, Vol. 2, Issue 8, pp. 732-40, (2014) (PubMed).
: "Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1." in: Biochemical pharmacology, Vol. 92, Issue 2, pp. 312-25, (2014) (PubMed).
: "38" in: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)
: "Porcine ?? T lymphocytes can be categorized into two functionally and developmentally distinct subsets according to expression of CD2 and level of TCR." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 190, Issue 5, pp. 2111-20, (2013) (PubMed).
: "Alteration of the thymic T cell repertoire by rotavirus infection is associated with delayed type 1 diabetes development in non-obese diabetic mice." in: PLoS ONE, Vol. 8, Issue 3, pp. e59182, (2013) (PubMed).
: "The expression of CD25, CD11b, SWC1, SWC7, MHC-II, and family of CD45 molecules can be used to characterize different stages of γδ T lymphocytes in pigs." in: Developmental and comparative immunology, Vol. 36, Issue 4, pp. 728-40, (2012) (PubMed).
: "Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays." in: The Journal of biological chemistry, Vol. 287, Issue 17, pp. 13829-39, (2012) (PubMed).
: "CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 5, pp. 2118-30, (2012) (PubMed).
Aliases for IL-2 蛋白
interleukin 2 (IL2) 蛋白interleukin 2 (il2) 蛋白
interleukin-15 (LOC100303688) 蛋白
interleukin 2 (Il2) 蛋白
IL-2 蛋白
Il-2 蛋白
IL2 蛋白
il2 蛋白
lymphokine 蛋白
POIL2 蛋白
TCGF 蛋白